Logo

Medicamen Biotech Share Price

Medicamen Biotech (INR)478.7-18.2   (-3.7%)

Exchange ScripsBSE531146NSEMEDICAMEQISININE646B01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Medicamen Biotech Performance

Market performance
Open price496.1
High501.85
Volumes18677
Prev Close478.7
Low476
Closing date2025-01-10
Historical performance
1 Year High630.00
3 Year High1225.00
5 Year High1225.00
1 Year Low355.45
3 Year Low355.45
5 Year Low355.45

Medicamen Biotech Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
605
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
64.11
Dividend Yield
Dividend Yield
0.02 %

Medicamen Biotech Investment Returns

1 Year
-16%
3 Years
-47.8%
5 Years
N/A
10 Years
N/A

Medicamen Biotech Technicals

IndicatorsValueSignal
5-DMA498.79Bearish
10-DMA506.36Bearish
20-DMA523.11Bearish
50-DMA512.01Bearish
100-DMA497.66Bearish
200-DMA480.35Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters11122
Foreign Investors---------------
Domestic Investors11122
Public Investors107911065110638102509417
Government---------------

Medicamen Biotech Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income2325178
Operating Profit258268258204
Interest57341915
Depreciation71645825
Profit Before Tax131170181164
Consolidated Net Profit95147149121
Adjusted EPS7121210

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital127127122122
Total Reserves1943178213431207
Minority Interest------------
Total Non-Current Liabilities576078
Total Liabilities2920276622521940
Capital Work in Progress------------
Total Assets2920276622521940

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities-67-6341128
Cash Flow from Investing Activities-56-59-85-178
Cash Flow from Financing Activitie632914358
Net Cash Inflow / Outflow-60170-18
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 64.11.
  • 3Y Stock Price CAGR of the stock is -18.1.
  • The stock has a beta of 1.5.
  • In the last financial year, the company had an EBITDA of ₹258 Million.
  • The company generated revenue of ₹1793 Million in the previous financial year.

Medicamen Biotech

478.7-18.2   (-3.7%)

Investment Amount: ₹ 58180
Current Value: ₹ 47870
Performance: -17.7%
P/L: ₹ -10310
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month